Amyris (NASDAQ:AMRS) reported Q1 EPS of ($0.37), $0.07 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $57.7 million versus the consensus estimate of $58.94 million.
Amyris (NASDAQ:AMRS) reported Q1 EPS of ($0.37), $0.07 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $57.7 million versus the consensus estimate of $58.94 million.